JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · Issues related to pharmaceutical drugs

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $20,000.00 income · posted Jul 14, 2025

Lobbying activity 3

Health Issues

Issue related to pharmaceutical compounding; Issues related to Domestic manufacturing;

Medicare/Medicaid

Implementation of the Inflation Reduction Act; Issues related to 340B

Trade (domestic/foreign)

Issues related to pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.